鄭重說明:

您值得信賴的中藥成分及標準合作伙伴滿足您研發和工業化需求

產品關鍵詞：香草酸-4-β-D-葡萄糖苷 6-甲氧基山奈酚茯苓新酸B 去甲異波爾定

guanyuwomen關于德思特

聯系方式

服務熱線：

028-8500-3950

公司傳真：	028-85589956
公司郵箱：	sales@tcmlmt.com
公司網址：	hamilton.org.cn
公司地址：	四川省成都市溫江區海科路西段128號5棟

發表文獻展示

當前位置:首頁關于德思特 > 發表文獻展示 >

Phytomedicine-14 May 2020 香蒲新苷 α-亞麻酸紫云英苷柚皮素

時間：2020-09-03 瀏覽次數：分享到：

Thrombin-based discovery strategy of bioactive-chemical quality marker combination for pollen of Typha orientalis by metabolomics coupled with chemometrics

期刊名：Phytomedicine
文獻編號：DOI 10.1016/j.phymed.2020.153246
文獻地址：https://www.sciencedirect.com/science/article/abs/pii/S0944711320300775?via%3Dihub
發表日期：14 May 2020

Abstract
Background
It is of utmost significance to choose the bioactive components as quality markers for ensuring the effectiveness of traditional Chinese medicine. Nonetheless, some markers are able to assess effectively the quality of TCM without considering the pharmacological mechanisms and intrinsic chemical complexities.

Objective
This underscores the need to discover new and efficient markers which can assess both quality and mechanism of action. Herein, a strategy of bioactive-chemical quality markers combination was proposed to improve the level of the quality control of TCM by metabolomics coupled with chemometrics.

Reference standards of typhaneoside, kaempferol-3-O-neohesperidoside, citric acid, linolenic acid, kaempferol-3-O-neohesperidoside, astragalin, naringenin, puerarin, and succinic acid with 98% purity on the basis of HPLC analysis were supplied by Chengdu Desite Biological Technology Co. Ltd. (Sichuan, China)

上一篇：Molecules-20 January 2020 白楊素芹菜素香葉木素山奈酚-7-O-葡萄

下一篇：Biochemical Pharmacology-13 May 2020 黃芩素